The first UK research study into the medical benefits of cannabis on Multiple Scelrosis has shown there is no benefit.
However there were benefits for those at the lower end of the disability scale.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from the Peninsula College of Medicine and Dentistry.
It enrolled nearly 500 people with MS from 27 centres around the UK, who were either given capsules containing the active ingredient of cannabis and some given a placebo.
Alison Smith, an MS sufferer took part in the trial:
More top news
As Labour's turmoil continues and the Tories deal with the fallout of Brexit, the Lib Dems think they have something to offer voters.
People are invited to share alleged racism or xenophobia stories after Brexit vote to highlight "need for a plan to tackle" social effects.
Tyson Fury says England should beat Iceland 10-nil because they're "not even a footballing nation", as he spoke about his Klitschko rematch.